Get Plus

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Kan NewsHealth

Ichilov Hospital Launches Parkinson’s Study Using Ohad Naharin’s Movement Language

Translated & summarized from Kan News by baba

Public

Hebrew · 2 newsrooms covering

Ichilov Hospital has started a pilot study with Israel Prize winner Ohad Naharin to test his "Gaga" movement language as a therapy for Parkinson’s patients, following promising trials in New York and Canada.

The story in 5 lines · by baba

  • Ichilov Hospital begins research on dance therapy for Parkinson’s with Ohad Naharin.
  • Naharin’s "Gaga" method is a movement language used for body strengthening and imagination.
  • Previous trials in New York and Canada showed improvement in Parkinson’s patients.
  • The Neurology and Movement Research Department at Ichilov initiated the collaboration.
  • The pilot study will scientifically document patient progress using Naharin’s method.
Ichilov Hospital Launches Parkinson’s Study Using Ohad Naharin’s Movement Language
Editorial illustration generated by baba News, not a photograph of the event.

Ichilov Hospital in Tel Aviv has initiated a new research project examining the effects of movement and dance therapy on Parkinson’s disease patients. The study is conducted in collaboration with Ohad Naharin, an acclaimed dancer and choreographer who received the Israel Prize. Naharin developed the movement language "Gaga," which goes beyond dance to serve as a method for body exploration, strengthening, and imagination enhancement.

Naharin previously applied the Gaga method in therapeutic settings with Parkinson’s patients in New York and Canada, observing improvements in their condition. Upon learning about his approach, Ichilov’s Neurology and Movement Research Department, which specializes in Parkinson’s treatment, reached out to collaborate. The current pilot study will involve Parkinson’s patients working directly with Naharin, with their progress monitored using scientific tools to evaluate potential benefits.

This initiative reflects a growing interest in innovative, non-pharmacological therapies for Parkinson’s disease, aiming to improve patients’ quality of life through physical and cognitive engagement. The research is in its early stages, and results will be closely analyzed to determine the method’s efficacy.

Kan NewsCentre · Jerusalem

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

HealthTopic

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

Mentioned

Full coverage · 2 outlets
First: Kan News · Jul 6

The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.

Open the Wire